DE3371786D1 - 1,2,4-triazine and pyrazine derivatives - Google Patents
1,2,4-triazine and pyrazine derivativesInfo
- Publication number
- DE3371786D1 DE3371786D1 DE8383301142T DE3371786T DE3371786D1 DE 3371786 D1 DE3371786 D1 DE 3371786D1 DE 8383301142 T DE8383301142 T DE 8383301142T DE 3371786 T DE3371786 T DE 3371786T DE 3371786 D1 DE3371786 D1 DE 3371786D1
- Authority
- DE
- Germany
- Prior art keywords
- triazine
- pyrazine derivatives
- gaba
- triazines
- diaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/16—Halogen atoms; Nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Luminescent Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
This invention relates to certain amino-5,6-diaryl-1,2,4--triazines and -pyrazines useful as activators of GABA and benzodiazepine binding.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/354,982 US4513135A (en) | 1982-03-05 | 1982-03-05 | Diaryl-pyrazine derivatives affecting GABA binding |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3371786D1 true DE3371786D1 (en) | 1987-07-02 |
Family
ID=23395746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8383301142T Expired DE3371786D1 (en) | 1982-03-05 | 1983-03-03 | 1,2,4-triazine and pyrazine derivatives |
Country Status (22)
Country | Link |
---|---|
US (2) | US4513135A (en) |
EP (1) | EP0088593B1 (en) |
JP (1) | JPS58162582A (en) |
KR (1) | KR860000847B1 (en) |
AT (1) | ATE27457T1 (en) |
AU (1) | AU547581B2 (en) |
CA (1) | CA1195327A (en) |
DD (1) | DD207716A5 (en) |
DE (1) | DE3371786D1 (en) |
DK (1) | DK97283A (en) |
ES (2) | ES520340A0 (en) |
FI (1) | FI830708L (en) |
GB (1) | GB2116179B (en) |
GR (1) | GR78459B (en) |
HU (1) | HU191368B (en) |
IL (1) | IL68002A (en) |
NZ (1) | NZ203428A (en) |
PH (1) | PH22535A (en) |
PL (1) | PL240871A1 (en) |
PT (1) | PT76312B (en) |
RO (1) | RO86320B (en) |
ZA (1) | ZA831387B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2567518B1 (en) * | 1984-07-11 | 1987-11-13 | Sanofi Sa | NOVEL NITROGEN HETEROCYCLIC CORE COMPOUNDS, THEIR PREPARATION AND THE MEDICINAL PRODUCTS CONTAINING THE SAME |
JPH06501926A (en) * | 1990-08-06 | 1994-03-03 | 藤沢薬品工業株式会社 | heterocyclic compound |
GB9420010D0 (en) * | 1994-10-01 | 1994-11-16 | Marck Sharp & Dohme Limited | Nucleic acids |
USRE41920E1 (en) | 1996-07-24 | 2010-11-09 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
TWI316055B (en) * | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
KR100490893B1 (en) * | 2002-10-11 | 2005-05-23 | (주) 비엔씨바이오팜 | 2-methoxy-1,3,5-triazine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
MX2007009224A (en) * | 2005-02-01 | 2008-03-13 | Lake Erie Products | Anti-cross threading fastener. |
CA2606288A1 (en) * | 2005-04-18 | 2006-10-26 | Neurogen Corporation | Subtituted heteroaryl cb1 antagonists |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
JP2009506069A (en) | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | Neurogenesis through modulation of muscarinic receptors |
CA2625153A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
US20070112017A1 (en) * | 2005-10-31 | 2007-05-17 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US7678808B2 (en) | 2006-05-09 | 2010-03-16 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
EP2377531A2 (en) | 2006-05-09 | 2011-10-19 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
PT2531492T (en) | 2010-02-05 | 2016-07-07 | Heptares Therapeutics Ltd | 1,2,4-triazine-4-amine derivatives |
GB201106829D0 (en) | 2011-04-21 | 2011-06-01 | Proximagen Ltd | Heterocyclic compounds |
TW201321353A (en) * | 2011-10-08 | 2013-06-01 | Novartis Ag | Carbamate/urea derivatives |
EP3484856B1 (en) * | 2016-07-12 | 2023-11-15 | Revolution Medicines, Inc. | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors |
US11339135B2 (en) | 2016-11-30 | 2022-05-24 | Mitsubishi Tanabe Pharma Corporation | Method for producing triazine compound |
BR112019014527A2 (en) | 2017-01-23 | 2020-02-27 | Revolution Medicines, Inc. | PYRIDINE COMPOUNDS AS ALLOSTIC SHP2 INHIBITORS |
EP3571199A1 (en) | 2017-01-23 | 2019-11-27 | Revolution Medicines, Inc. | Bicyclic compounds as allosteric shp2 inhibitors |
EP3678703A1 (en) | 2017-09-07 | 2020-07-15 | Revolution Medicines, Inc. | Shp2 inhibitor compositions and methods for treating cancer |
AU2018347516A1 (en) | 2017-10-12 | 2020-05-07 | Revolution Medicines, Inc. | Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors |
MX2020006273A (en) | 2017-12-15 | 2020-09-14 | Revolution Medicines Inc | Polycyclic compounds as allosteric shp2 inhibitors. |
IL300091A (en) | 2018-05-01 | 2023-03-01 | Revolution Medicines Inc | C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors |
EP3788050A1 (en) | 2018-05-01 | 2021-03-10 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mtor inhibitors |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3172889A (en) * | 1965-03-09 | Process for the separation of z-methyl- | ||
US3294638A (en) * | 1961-06-05 | 1966-12-27 | Warner Lambert Pharmaceutical | Method and compositions employing 2-alkyl-3-piperidinopyrazines |
CH480795A (en) * | 1967-03-01 | 1969-11-15 | Sandoz Ag | Preparations for influencing plant growth |
US3948894A (en) * | 1974-01-31 | 1976-04-06 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
US3989831A (en) * | 1974-01-31 | 1976-11-02 | Eli Lilly And Company | Topically-active anti-inflammatory 3-chloro-5,6-diaryl-1,2,4-triazines |
US3979516A (en) * | 1974-01-31 | 1976-09-07 | Eli Lilly And Company | Anti-inflammatory 3-amino-5,6-diaryl-1,2,4-triazines |
US4013654A (en) * | 1974-01-31 | 1977-03-22 | Eli Lilly And Company | 5,6-diaryl-1,2,4-triazines |
US4081542A (en) * | 1975-04-21 | 1978-03-28 | Merck & Co., Inc. | Piperazinylpyrazines |
GB1493998A (en) * | 1975-06-03 | 1977-12-07 | Beecham Group Ltd | Propanolamine derivatives |
US4008232A (en) * | 1975-06-23 | 1977-02-15 | Eli Lilly And Company | 3-Amino-5,6-diaryl-1,2,4-triazines |
US4082844A (en) * | 1976-02-09 | 1978-04-04 | Merck & Co., Inc. | 6-chloro-2-(1-piperazinyl)pyrazine |
US4018923A (en) * | 1976-03-10 | 1977-04-19 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
US4190725A (en) * | 1976-03-10 | 1980-02-26 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines |
US4021553A (en) * | 1976-03-10 | 1977-05-03 | Eli Lilly And Company | 5,6-Diaryl-1,2,4-triazines as topically-active anti-inflammatory agents |
NL7802514A (en) * | 1977-03-09 | 1978-09-12 | Fabre Sa Pierre | 5,6-DIARYL-1,2,4-TRIAZINE DERIVATIVES AND METHOD FOR PREPARING THESE COMPOUNDS. |
US4251527A (en) * | 1977-05-17 | 1981-02-17 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
CH633541A5 (en) * | 1977-05-17 | 1982-12-15 | Diamond Shamrock Corp | Pharmacologically active substituted 1,2,4-triazines and medicaments containing these triazines |
US4157392A (en) * | 1977-05-17 | 1979-06-05 | Diamond Shamrock Corporation | Pharmacologically active substituted 1,2,4-triazines |
-
1982
- 1982-03-05 US US06/354,982 patent/US4513135A/en not_active Expired - Fee Related
-
1983
- 1983-02-28 IL IL68002A patent/IL68002A/en unknown
- 1983-02-28 DK DK97283A patent/DK97283A/en not_active Application Discontinuation
- 1983-02-28 RO RO110181A patent/RO86320B/en unknown
- 1983-03-01 PT PT76312A patent/PT76312B/en unknown
- 1983-03-01 NZ NZ203428A patent/NZ203428A/en unknown
- 1983-03-01 PH PH28587A patent/PH22535A/en unknown
- 1983-03-01 ZA ZA831387A patent/ZA831387B/en unknown
- 1983-03-02 JP JP58035221A patent/JPS58162582A/en active Pending
- 1983-03-02 KR KR1019830000833A patent/KR860000847B1/en active
- 1983-03-02 FI FI830708A patent/FI830708L/en not_active Application Discontinuation
- 1983-03-03 GB GB08305846A patent/GB2116179B/en not_active Expired
- 1983-03-03 EP EP83301142A patent/EP0088593B1/en not_active Expired
- 1983-03-03 AT AT83301142T patent/ATE27457T1/en not_active IP Right Cessation
- 1983-03-03 DE DE8383301142T patent/DE3371786D1/en not_active Expired
- 1983-03-03 AU AU12029/83A patent/AU547581B2/en not_active Ceased
- 1983-03-03 CA CA000422805A patent/CA1195327A/en not_active Expired
- 1983-03-04 HU HU83762A patent/HU191368B/en unknown
- 1983-03-04 PL PL24087183A patent/PL240871A1/en unknown
- 1983-03-04 GR GR70688A patent/GR78459B/el unknown
- 1983-03-04 ES ES520340A patent/ES520340A0/en active Granted
- 1983-03-04 DD DD83248497A patent/DD207716A5/en unknown
- 1983-10-06 ES ES526297A patent/ES526297A0/en active Granted
-
1985
- 1985-01-04 US US06/688,946 patent/US4585861A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US4513135A (en) | 1985-04-23 |
EP0088593A3 (en) | 1984-05-23 |
ES8504173A1 (en) | 1985-04-16 |
DD207716A5 (en) | 1984-03-14 |
NZ203428A (en) | 1986-09-10 |
ES526297A0 (en) | 1985-04-16 |
GR78459B (en) | 1984-09-27 |
HU191368B (en) | 1987-02-27 |
IL68002A (en) | 1986-09-30 |
ES8404346A1 (en) | 1984-04-16 |
KR840004101A (en) | 1984-10-06 |
IL68002A0 (en) | 1983-06-15 |
FI830708A0 (en) | 1983-03-02 |
EP0088593A2 (en) | 1983-09-14 |
GB8305846D0 (en) | 1983-04-07 |
AU547581B2 (en) | 1985-10-24 |
PT76312B (en) | 1986-02-04 |
PT76312A (en) | 1983-04-01 |
GB2116179A (en) | 1983-09-21 |
ES520340A0 (en) | 1984-04-16 |
RO86320B (en) | 1985-03-31 |
PH22535A (en) | 1988-10-17 |
US4585861A (en) | 1986-04-29 |
ATE27457T1 (en) | 1987-06-15 |
ZA831387B (en) | 1984-10-31 |
JPS58162582A (en) | 1983-09-27 |
AU1202983A (en) | 1983-09-08 |
PL240871A1 (en) | 1984-06-18 |
DK97283D0 (en) | 1983-02-28 |
GB2116179B (en) | 1985-09-11 |
CA1195327A (en) | 1985-10-15 |
DK97283A (en) | 1983-09-06 |
FI830708L (en) | 1983-09-06 |
EP0088593B1 (en) | 1987-05-27 |
KR860000847B1 (en) | 1986-07-09 |
RO86320A (en) | 1985-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2116179B (en) | 1,2,4-triazine and pyrazine derivatives | |
ES8801546A1 (en) | Improvements in the treatment of tumors in mammals. | |
ES8606289A1 (en) | Anti-virally active pyridazinamines. | |
ES8305761A1 (en) | Bicyclic lactams as antihypertensives. | |
DE3369590D1 (en) | Bismaleimide triazine composition | |
ES8203375A1 (en) | Triazoloquinoxalin-4-ones and such oxaline-4-thiones. | |
EP0116628A4 (en) | 1-acyl-3-pyridylmethylguanidines and their use as antihypertensive agents. | |
ES8507530A1 (en) | Novel aryloxycycloalkanolaminoalkylene aryl ketones. | |
SU1089968A1 (en) | Magnetorheological suspension | |
MX9602767A (en) | N,n-diethyl-8,8-dipropyl-2-azaspiro (4,5)decane-2-propanamine dimaleate. | |
IT1170227B (en) | ANKLE FOR THE ASSEMBLY OF FURNITURE PARTS | |
SU1256381A1 (en) | Method of processing rare-earth concentrate | |
SU1083739A1 (en) | Stokes-calibrator | |
RO87212B1 (en) | P-fluorobenzamide derivatives | |
SU1111454A1 (en) | Method of obtaining (4,6-disubstituted pyrimidinyl-2-thiophanibromides | |
SU1154903A1 (en) | Method of obtaining 2-imino-3-phenyl-6-phenacyliden-2,3,5,6-tetrahydro-1,3,4-oxadiazin-5-ones | |
SU1122635A1 (en) | Caked composition material | |
SU1220308A1 (en) | Derivatives of dihydropirrolo[1,2,3-<e,d>] pyramido [4,5-<b>] pyrazin or dihydropirrolo [1,2,3-<b, d>] pyramido [4,5-<b>] diazepin and method of obtaining the same | |
SU1086938A1 (en) | Method of holographic matched filtering | |
SU1195570A1 (en) | Trunk-tent for vehicle | |
SU1217054A1 (en) | Stokes-modulator | |
SU1120886A1 (en) | P-i-n-DIODE | |
SU1114135A1 (en) | Manotron |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Free format text: SPOTT, G., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN |
|
8339 | Ceased/non-payment of the annual fee |